Condensed Consolidated Statement of Shareholders' Deficit (Unaudited) - USD ($)	Series C Convertible Preferred Stock [Member]	Series D Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning Balance at Dec. 31, 2017	$ 1	$ 9,072	$ 649,149	$ 77,931,051	$ (78,246,343)	$ 342,930
Beginning Balance, shares at Dec. 31, 2017	33.326899	907,144	64,914,935
Stock-based Compensation Expense related to Stock Option Grants				13,335		13,335
Net loss					(332,635)	(332,635)
Ending Balance at Mar. 31, 2018	$ 1	$ 9,072	$ 649,149	77,944,386	(78,578,978)	23,630
Ending Balance, shares at Mar. 31, 2018	33.326899	907,144	64,914,935
Beginning Balance at Dec. 31, 2017	$ 1	$ 9,072	$ 649,149	77,931,051	(78,246,343)	342,930
Beginning Balance, shares at Dec. 31, 2017	33.326899	907,144	64,914,935
Net loss						(793,569)
Ending Balance at Sep. 30, 2018		$ 9,072	$ 681,050	78,062,729	(79,039,912)	(287,061)
Ending Balance, shares at Sep. 30, 2018	11.469249	907,144	68,104,957
Beginning Balance at Mar. 31, 2018	$ 1	$ 9,072	$ 649,149	77,944,386	(78,578,978)	23,630
Beginning Balance, shares at Mar. 31, 2018	33.326899	907,144	64,914,935
Stock-based Compensation Expense related to Stock Option Grants				13,335		13,335
Stock option exercises			$ 500	1,500		2,000
Stock option exercises, shares			50,000
Net loss					(260,062)	(260,062)
Ending Balance at Jun. 30, 2018	$ 1	$ 9,072	$ 649,649	77,959,221	(78,839,040)	(221,097)
Ending Balance, shares at Jun. 30, 2018	33.326899	907,144	64,964,935
Stock-based Compensation Expense related to Stock Option Grants				12,779		12,779
Conversion of Series C Convertible Preferred Stock	$ (1)		$ 10,001	26,529		36,529
Conversion of Series C Convertible Preferred Stock, shares	(21,857,650)		1,000,022
Stock option exercises			$ 21,400	64,200		85,600
Stock option exercises, shares			2,140,000
Net loss					(200,872)	(200,872)
Ending Balance at Sep. 30, 2018		$ 9,072	$ 681,050	78,062,729	(79,039,912)	(287,061)
Ending Balance, shares at Sep. 30, 2018	11.469249	907,144	68,104,957
Beginning Balance at Dec. 31, 2018		$ 9,072	$ 681,050	78,069,200	(79,191,451)	(432,129)
Beginning Balance, shares at Dec. 31, 2018	11.469249	907,144	68,104,957
Stock-based Compensation Expense related to Stock Option Grants				4,836		4,836
Net loss					(197,488)	(197,488)
Ending Balance at Mar. 31, 2019		$ 9,072	$ 681,050	78,074,036	(79,388,939)	(624,781)
Ending Balance, shares at Mar. 31, 2019	11.469249	907,144	68,104,957
Beginning Balance at Dec. 31, 2018		$ 9,072	$ 681,050	78,069,200	(79,191,451)	(432,129)
Beginning Balance, shares at Dec. 31, 2018	11.469249	907,144	68,104,957
Net loss						(455,971)
Ending Balance at Sep. 30, 2019		$ 9,072	$ 681,050	78,083,708	(79,647,422)	(873,592)
Ending Balance, shares at Sep. 30, 2019	11.469249	907,144	68,104,957
Beginning Balance at Mar. 31, 2019		$ 9,072	$ 681,050	78,074,036	(79,388,939)	(624,781)
Beginning Balance, shares at Mar. 31, 2019	11.469249	907,144	68,104,957
Stock-based Compensation Expense related to Stock Option Grants				4,836		4,836
Net loss					(74,235)	(74,235)
Ending Balance at Jun. 30, 2019		$ 9,072	$ 681,050	78,078,872	(79,463,174)	(694,180)
Ending Balance, shares at Jun. 30, 2019	11.469249	907,144	68,104,957
Stock-based Compensation Expense related to Stock Option Grants				4,836		4,836
Net loss					(184,248)	(184,248)
Ending Balance at Sep. 30, 2019		$ 9,072	$ 681,050	$ 78,083,708	$ (79,647,422)	$ (873,592)
Ending Balance, shares at Sep. 30, 2019	11.469249	907,144	68,104,957